Healthcare Tips: FDA asks Teva Pharmaceutical for further study on Huntington drug

JERUSALEM (Reuters) - Israel-based Teva Pharmaceutical Industries said on Tuesday approval for a drug to treat chorea stemming from Huntington disease (HD) has been held up by U.S. regulators seeking further blood study.

Read more: FDA asks Teva Pharmaceutical for further study on Huntington drug